Key Highlights:
- Ubisoft’s stock plummets to 10-year low following Star Wars Outlaws release.
- Star Wars Outlaws underperforms in sales and receives mixed reviews.
- Ubisoft’s financial future hinges on upcoming releases like Assassin’s Creed Shadows.
Gaming giant Ubisoft has seen its stock price tumble to a decade-long low, sparking concerns about the company’s future in the competitive gaming market.
The recent release of Star Wars Outlaws, which was expected to be a major hit, has instead become a point of contention for both fans and investors alike.
Star Wars Outlaws, Ubisoft’s latest foray into the beloved sci-fi universe, has struggled to meet expectations since its launch.
Early sales figures paint a worrying picture, with physical launch sales in the UK falling 55% short of last year’s Star Wars: Jedi Survivor. While digital sales data is still pending, these initial numbers have sent shockwaves through the industry.
The game’s reception has been lukewarm at best. Despite a respectable Metacritic score of 76, user reviews have been far less forgiving, resulting in a “generally unfavourable” user score of 4.9. This disconnect between critic and user opinions has left many questioning the game’s overall quality and appeal.
The financial impact of Star Wars Outlaws’ underwhelming performance has been swift and severe.
As first reported by InsiderGaming, Ubisoft’s share price plummeted by over 10% in just two days following the game’s release, pushing the company’s market value below the two billion mark in both Euros and US Dollars. This sharp decline has brought Ubisoft’s stock to its lowest point since 2014, a clear sign of investor unease.
Industry analysts have been quick to react, with J.P. Morgan slashing its sales forecast for Star Wars Outlaws by a staggering two million units. The revised prediction of 5.5 million copies sold by next March paints a grim picture for the company’s financial outlook.
Though, it’s not all doom and gloom for the French publisher. Ubisoft’s Q1 2024 financial report showed some promising signs, with sales up 12% year-on-year at €323.5 million and net bookings increasing by 8.3% to €290 million. These results were largely driven by the success of the free-to-play title XDefiant and pre-orders for the upcoming Assassin’s Creed Shadows.
Looking ahead, Ubisoft will be pinning its hopes on Assassin’s Creed Shadows to turn the tide.
Early indicators are positive, with the title’s premium €280 edition already selling out in some regions. However, the company faces an uphill battle in regaining player trust and investor confidence.
As Ubisoft navigates these choppy waters, questions arise about the company’s overall strategy and the changing tastes of gamers.
Some critics argue that Ubisoft’s recent offerings have failed to capture the magic of their earlier successes, while others point to broader industry trends and increased competition as factors in the company’s struggles.
Letting go of iconic mascots like Rayman and Sam Fisher doesn’t help matters. Fans were disappointed not to see anything in regards to the Splinter Cell series at the last Ubisoft Forward event. There is suppose to be a big remake of the first game but the publisher hasn’t updated fans on its status in years.
In the coming months the success or failure of Assassin’s Creed Shadows may well determine the company’s trajectory for years to come. With how good it looks, and the strength of the series, it will take a brave person to bet against its success.
